KZA kazia therapeutics limited

sec filing - novogen yale uni joint venture , page-21

  1. 35 Posts.
    Certainly doesn't look good regarding the share price.

    The sell side has more than doubled than where it was a couple days back and the buy side has thinned considerably. Without some other positive news it looks like the share price will fall to around the .18 mark.

    Would the market reaction be as a result of the 85% stake that novogen has received via the partnership. Maybe many investments would view that as a dilution of 15%.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.